Why Amarin Stock Tumbled in November

·2 min read
Why Amarin Stock Tumbled in November

Shares of the cardiovascular disease specialist Amarin (NASDAQ: AMRN) lost approximately a quarter of their value during the month of November, according to data from S&P Global Market Intelligence. Rather, Amarin's stock appears to have simply followed the broader biotech space downward last month. Amarin's shares, in particular, were probably a victim of year-end tax-loss selling last month.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting